Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lucidin 3-o-beta-primveroside
2. Lucidin 3-o-primveroside
1. Lucidin Primeveroside
2. 29706-59-0
3. Lucidin 3-o-primeveroside
4. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
5. Lucidin 3-o-beta-primveroside
6. 1-hydroxy-2-(hydroxymethyl)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2s,3r,4s,5r)-3,4,5-trihydroxytetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)anthracene-9,10-dione
7. 9,10-anthracenedione, 1-hydroxy-2-(hydroxymethyl)-3-[(6-o-beta-d-xylopyranosyl-beta-d-glucopyranosyl)oxy]-
8. Ccris 4532
9. Lucidin 3-o-primveroside
10. Lucidin Primevoroside
11. Lucidin-primeveroside
12. Chembl521217
13. Schembl23522435
14. Dtxsid40952155
15. Hy-n8022
16. Zinc42878492
17. Glucopyranoside, 4-hydroxy-3-(hydroxymethyl)-2-anthraquinonyl 6-o-beta-d- Xylopyranosyl-, Beta-d-
18. Cs-0138995
19. E88947
20. 1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxytetrahydropyran-2-yl]oxymethyl]tetrahydropyran-2-yl]oxy-anthracene-9,10-dione
21. 4-hydroxy-3-(hydroxymethyl)-9,10-dioxo-9,10-dihydroanthracen-2-yl 6-o-pentopyranosylhexopyranoside
22. Ncgc00384986-01!1-hydroxy-2-(hydroxymethyl)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2s,3r,4s,5r)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxan-2-yl]oxyanthracene-9,10-dione
| Molecular Weight | 564.5 g/mol |
|---|---|
| Molecular Formula | C26H28O14 |
| XLogP3 | -2.1 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 14 |
| Rotatable Bond Count | 6 |
| Exact Mass | 564.14790556 g/mol |
| Monoisotopic Mass | 564.14790556 g/mol |
| Topological Polar Surface Area | 233 Ų |
| Heavy Atom Count | 40 |
| Formal Charge | 0 |
| Complexity | 918 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 9 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Lucidinprimeveroside manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lucidinprimeveroside, including repackagers and relabelers. The FDA regulates Lucidinprimeveroside manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lucidinprimeveroside API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Lucidinprimeveroside supplier is an individual or a company that provides Lucidinprimeveroside active pharmaceutical ingredient (API) or Lucidinprimeveroside finished formulations upon request. The Lucidinprimeveroside suppliers may include Lucidinprimeveroside API manufacturers, exporters, distributors and traders.
Lucidinprimeveroside Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lucidinprimeveroside GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lucidinprimeveroside GMP manufacturer or Lucidinprimeveroside GMP API supplier for your needs.
A Lucidinprimeveroside CoA (Certificate of Analysis) is a formal document that attests to Lucidinprimeveroside's compliance with Lucidinprimeveroside specifications and serves as a tool for batch-level quality control.
Lucidinprimeveroside CoA mostly includes findings from lab analyses of a specific batch. For each Lucidinprimeveroside CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lucidinprimeveroside may be tested according to a variety of international standards, such as European Pharmacopoeia (Lucidinprimeveroside EP), Lucidinprimeveroside JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lucidinprimeveroside USP).
LOOKING FOR A SUPPLIER?
